PWS Clinical Trial Webinar: Cannabidiol (CBD)

A new study is now enrolling patients ages 8 – 17 to determine the safety and efficacy of Cannabidiol (CDB) for the treatment of hyperphagia and compulsive behaviors in PWS.

If you are interested in learning more about this trial, watch this 20-minute webinar to learn more about the study, what you can expect if you choose to participate, and eligibility criteria for participation.